|
Volumn 30, Issue 2, 1998, Pages 505-506
|
First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DIABETES MELLITUS;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MALE;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADULT;
DIABETES MELLITUS;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
TACROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0031967173
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)01377-8 Document Type: Conference Paper |
Times cited : (6)
|
References (6)
|